A 5289 – New York
Status: In ProcessYear Introduced: 2021
Link: https://www.nysenate.gov/legislation/bills/2021/A5289
Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient and record the request.
Key Issues:
PHARMACEUTICALS
Biosimilar or Generic Competition
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found